157 related articles for article (PubMed ID: 30964326)
21. Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice.
Nobre LMS; da Silva Lopes MH; Geraix J; Cajado AG; Silva JMR; Ribeiro LR; Freire RS; Cavalcante DIM; Wong DVT; Alves APNN; Lima-Júnior RCP
Life Sci; 2022 May; 296():120445. PubMed ID: 35245522
[TBL] [Abstract][Full Text] [Related]
22. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.
Bastos RW; Pedroso SH; Vieira AT; Moreira LM; França CS; Cartelle CT; Arantes RM; Generoso SV; Cardoso VN; Neves MJ; Nicoli JR; Martins FS
Benef Microbes; 2016 Sep; 7(4):549-57. PubMed ID: 27133563
[TBL] [Abstract][Full Text] [Related]
23. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
[TBL] [Abstract][Full Text] [Related]
24. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
[TBL] [Abstract][Full Text] [Related]
25. Preventive oral supplementation with
Ribeiro WR; Queiroz AG; Mendes E; Casaro MB; Nascimento CM; Coelho LSSF; Martins FS; Leite-Silva VR; Ferreira CM
Benef Microbes; 2021 Apr; 12(2):199-209. PubMed ID: 33573507
[TBL] [Abstract][Full Text] [Related]
26. Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis.
Fakiha K; Coller JK; Logan RM; Gibson RJ; Bowen JM
Support Care Cancer; 2019 Jun; 27(6):2313-2320. PubMed ID: 30350190
[TBL] [Abstract][Full Text] [Related]
27. Absorption and Distribution of Selenium Following Oral Administration of Selenium-Enriched Bifidobacterium longum DD98, Selenized Yeast, or Sodium Selenite in Rats.
Zhou Y; Zhu H; Qi Y; Wu C; Zhang J; Shao L; Tan J; Chen D
Biol Trace Elem Res; 2020 Oct; 197(2):599-605. PubMed ID: 31845206
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial DNA as a Possible Ligand for TLR9 in Irinotecan-induced Small Intestinal Mucositis.
Ávila TV; Menezes-Garcia Z; do Nascimento Arifa RD; Soriani FM; Machado AMV; Teixeira MM; Fagundes CT; Souza DG
Immunol Invest; 2022 Aug; 51(6):1756-1771. PubMed ID: 35152824
[TBL] [Abstract][Full Text] [Related]
29. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
[TBL] [Abstract][Full Text] [Related]
30. Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model.
Thorpe D; Butler R; Sultani M; Vanhoecke B; Stringer A
Pathol Oncol Res; 2020 Apr; 26(2):955-965. PubMed ID: 30919275
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
32. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
[TBL] [Abstract][Full Text] [Related]
33. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a single-dose irinotecan model of gastrointestinal mucositis.
Gibson RJ; Bowen JM; Alvarez E; Finnie J; Keefe DM
Chemotherapy; 2007; 53(5):360-9. PubMed ID: 17713326
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
[TBL] [Abstract][Full Text] [Related]
36. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
[TBL] [Abstract][Full Text] [Related]
37. IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.).
Wang X; Zhu S; Qian L; Gao J; Wu M; Gao J; Zhang Y; Chan GL; Yu Y; Han W
Pharmacol Res; 2014 Apr; 82():21-33. PubMed ID: 24681512
[TBL] [Abstract][Full Text] [Related]
38. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea.
Wong DVT; Holanda RBF; Cajado AG; Bandeira AM; Pereira JFB; Amorim JO; Torres CS; Ferreira LMM; Lopes MHS; Oliveira RTG; Pereira AF; Sant'Ana RO; Arruda LM; Ribeiro-Júnior HL; Pinheiro RF; Almeida PRC; Carvalho RF; Chaves FF; Rocha-Filho DR; Cunha FQ; Lima-Júnior RCP
Br J Pharmacol; 2021 Oct; 178(20):4193-4209. PubMed ID: 34216140
[TBL] [Abstract][Full Text] [Related]
39. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
[TBL] [Abstract][Full Text] [Related]
40. The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis.
Nogueira LT; Costa DV; Gomes AS; Martins CS; Silva AM; Coelho-Aguiar JM; Castelucci P; Lima-Júnior RC; Leitão RF; Moura-Neto V; Brito GA
J Neuroinflammation; 2017 Apr; 14(1):79. PubMed ID: 28388962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
